ClinVar Miner

Submissions for variant NM_002386.3(MC1R):c.451C>T (p.Arg151Cys) (rs1805007)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000255991 SCV000321867 pathogenic not provided 2016-10-12 criteria provided, single submitter clinical testing The R151C variant in the MC1R gene has been reported previously in association with red hair, fair skin, increased risk for melanoma, increased risk of photoaging and congenital melanocytic nevi (Puig-Butille et al., 2013; Elfakir et al., 2010; Kinsler et al., 2012). Functional characterization of the R151C variant show a dominant negative effect on expression, which results in a decrease in the receptor's ability to elevate intracellular cAMP levels and a complete loss of receptor function at the cell surface (Beaumont et al., 2007; Sanchez-Laorden et al., 2009). The R151C variant is a non-conservative amino acid substitution of a positively-charged Arginine with a neutral Cysteine at a residue that is conserved across species. The R151C variant was observed with a frequency of 7.6%, 655/8600 alleles, and 1.7%, 75/4396 alleles, in individuals of European and African American ancestries, respectively, in the NHLBI Exome Sequencing Project. In addition, the R151C variant was observed with a frequency of 3% among the various ethnic groups studied in the 1000 Genomes Project. We interpret R151C in the MC1R gene as a pathogenic variant.
Illumina Clinical Services Laboratory,Illumina RCV000395364 SCV000399954 likely benign Malignant Melanoma Susceptibility 2016-06-14 criteria provided, single submitter clinical testing
Invitae RCV000472249 SCV000556936 benign Cutaneous malignant melanoma 5 2017-08-04 criteria provided, single submitter clinical testing
OMIM RCV000015385 SCV000035646 association Skin/hair/eye pigmentation 2, red hair/fair skin 2015-05-01 no assertion criteria provided literature only
OMIM RCV000015386 SCV000035647 affects Increased analgesia from kappa-opioid receptor agonist, female-specific 2015-05-01 no assertion criteria provided literature only
OMIM RCV000015387 SCV000035648 risk factor OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF 2015-05-01 no assertion criteria provided literature only
PreventionGenetics RCV000242808 SCV000308868 benign not specified criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.